Icon
+91 94997 68112
Login Register

Femara - (2.5 mg; Tablet)

Letrozole Novartis
2.5 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
More Than 5
More Than 5
Indicated for first-line treatment of postmenopausal women with hormone receptor-positive or unknown, locally advanced, or metastatic breast cancer
Yes
***** ***** *** *** ******. ***** ******** ******** ** *** ****, ***** ***** *** ********** *** ******* ***** ********* ** *** ***** ** ********* ***** *** ****** ** ** ****. ***** **** ***** **** ********* ***; ******, ******, ********* **** *** **** **** ********* *********. ** ******* ******* ***** ********* *** ********* ** **** **** ********* ** ********* *** *********. ** ** ***** **** ***** ******** ****** ********* ** **********. *** **** ***** ***** **** ********* ******** *** *******.
  1. ***, **** : ***** ******** ******** ***** *** **** ** ******** ****** '***.
  2. ****, **** : ******** **** ***** ** ******** ***** ** *** ******.
  3. ***, **** : ******** *** ***** ***** ********** ***** ***** **** ****** *** ******* ** ** ****. **** ********** ***** ** ********* *** ** ***** ********* ******** ** *** ****.
  4. ***** **, **** : ***** ******** *** *******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.